LinQNotes

Structured data tells you what happened. LinQNotes helps you understand why.

Access to the patient’s real story has long been buried in unstructured clinical notes. LinQNotes is an exploratory tool that allows users to search and interact with unstructured clinical data—giving commercial teams direct visibility into how care is delivered, where access breaks down, and what drives provider decisions. From launch planning to payer engagement to brand strategy, LinQNotes reveals the “why” behind treatment behaviors and adoption barriers—straight from the clinical narrative.

Ready to uncover the “why”?

Interrogate the Narrative

Search de-identified notes to see how physicians describe symptoms, therapies, and care decisions in their own words.

Align Strategy with Reality

Refine access strategy and brand messaging based on how real-world decisions are documented across diverse providers.

Use Flexible Free-Text Search

Use keywords, phrases, ICD codes, or biomarker terms to uncover insights hidden beyond structured fields.

Get Directional Volume Visibility

See counts of matched notes and patients to estimate population size – ideal for pre-launch planning or early signal detection.

How We Help

Using cutting edge technology combined with manual stewardship, MMIT provides a custom bridging file and services that will help maintain accuracy and completeness in an ever-changing industry by applying client specific business rules where necessary.

Detect Access Barriers

Pinpoint delays caused by prior auth, step edits, or payer rejections - captured in clinical notes - to support launch readiness and payer positioning.

Uncover Site of Care Challenges

Identify workflow issues, site-level friction, or care coordination gaps that claims can’t capture, supporting broader market shaping.

Understand Prescribing Behavior

Track how providers describe treatment decisions, brand preference, hesitation, or biomarker use - guiding messaging, field engagement and segmentation.

Spot Early Adoption Signals

Catch emerging mentions of novel therapies or off-label use ahead of structured data - informing launch strategy and competitive response.

Stay In Touch

Be the first to know about new arrivals and promotions

Reducing Risk: 5 Steps for a Fearless Launch